Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat.

scientific article

Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S001340050241
P698PubMed publication ID9120116

P2093author name stringB W Böttiger
M Fischer
K A Hossmann
S Popov-Cenic
P2860cites workBehavioral performance of rats following transient forebrain ischemiaQ48671719
Cerebral blood flow dynamics in hypotension and cardiac arrestQ48685149
The topography of impaired micro vascular perfusion in the primate brain following total circulatory arrestQ48723246
Studies on Mechanisms of Impairment of Cerebral Circulation Following Ischemia: Effect of Hemodilution and Perfusion PressureQ48731085
Neuronal survival and revival during and after cerebral ischemiaQ48741414
Effect of fibrinolytic activation on survival and cerebral damage following periods of circulatory arrest.Q51330493
Activation of Blood Coagulation After Cardiac Arrest Is Not Balanced Adequately by Activation of Endogenous FibrinolysisQ51590965
Resuscitation potentials after prolonged global cerebral ischemia in cats.Q51767028
Small-volume resuscitation with hypertonic saline (2,400 mOsm/liter) during hemorrhagic shock.Q54480986
Cerebral blood flow immediately following brief circulatory stasisQ66968671
Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarctionQ68073023
Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitroQ71576230
No-reflow after cardiac arrestQ72299322
Effect of intravascular platelet aggregation on blood recirculation following prolonged ischemia of the cat brainQ72605477
Blood-damaged tissue interaction in experimental brain ischemiaQ72846961
The mechanism of death after resuscitation following acute circulatory failureQ73807150
Recovery of integrative central nervous function after one hour global cerebro-circulatory arrest in normothermic cat.Q34191707
Cerebral ischemia. II. The no-reflow phenomenonQ36051400
NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischemiaQ36737566
Cortical hypoperfusion after global forebrain ischemia in rats is not caused by microvascular leukocyte pluggingQ36748256
Brain resuscitation by extracorporeal circulation after prolonged cardiac arrest in catsQ36782108
Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrestQ38137424
Microcirculatory therapy in shockQ38307311
Use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. II. Gasometric investigations of arterial bloodQ39079782
Changes of plasma volume and hematocrit after circulatory arrest: an experimental study in dogsQ39264194
Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolismQ40562009
Ischemia-mediated neuronal injuryQ40728466
Cerebral resuscitation after cardiac arrest: research initiatives and future directionsQ40876897
Dynamic heterogeneity of cerebral hypoperfusion after prolonged cardiac arrest in dogs measured by the stable xenon/CT technique: a preliminary studyQ41083592
Volume expansion during cardiopulmonary resuscitation reduces cerebral no-reflowQ41220087
Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboonsQ42460521
Thrombolysis following pre-hospital cardiopulmonary resuscitationQ43901014
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).Q44086439
Research work on blood clotting system during cardiorespiratory resuscitationQ44831774
Thrombolytic therapy in patients requiring cardiopulmonary resuscitationQ45152428
Coagulopathy following experimental cerebral ischemiaQ45260941
The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting systemQ46541028
The effect of combined dextran and streptokinase on cerebral function and blood flow after cardiac arrest: and experimental study on the dog.Q48147150
Capillary perfusion during incomplete forebrain ischemia and reperfusion in rat brainQ48245737
Cerebral microembolization. I. Pathophysiological studiesQ48252988
Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow phenomenon"Q48327367
The effects of heparin on recovery from ischemic brain injuries in catsQ48365959
Reference and working memory of rats following hippocampal damage induced by transient forebrain ischemiaQ48398288
Amelioration of Brain Damage After 12 Minutes' Cardiac Arrest in DogsQ48404411
Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemiaQ48606248
P433issue11
P921main subjectthrombolysisQ1931577
heparinQ190016
cardiac arrestQ202837
resuscitationQ5491454
plasminogenQ107129060
P304page(s)1214-1223
P577publication date1996-11-01
P1433published inIntensive Care MedicineQ15749164
P1476titleThrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat.
P478volume22

Reverse relations

cites work (P2860)
Q41446732Alterations in Cerebral Blood Flow after Resuscitation from Cardiac Arrest
Q47794243Association of antiplatelet therapy with patient outcomes after out-of-hospital cardiac arrest
Q38016122Cardiopulmonary resuscitation and management of cardiac arrest
Q50177361Cerebral microcirculatory alterations and the no-reflow phenomenon in vivo after experimental pediatric cardiac arrest.
Q30234832Clinical pathophysiology of hypoxic ischemic brain injury after cardiac arrest: a "two-hit" model
Q36465364Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest
Q42369766Coagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome
Q42787676Comments on the 2010 guidelines on cardiopulmonary resuscitation of the European Resuscitation Council
Q36068542Current and future therapies of pediatric cardiopulmonary arrest
Q34789731Effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation in a porcine model
Q37734973Outcome of out-of-hospital cardiac arrest after fibrinolysis with reteplase in comparison to the return of spontaneous circulation after cardiac arrest score in a geographic region without emergency coronary intervention
Q33258227Role of thrombolytic agents in cardiac arrest
Q28200168The new 2005 resuscitation guidelines of the European Resuscitation Council: comments and supplements
Q78833595The risk of thrombolysis in association with cardiopulmonary resuscitation: no reason to withhold this causal and effective therapy
Q83331731Therapeutic hypothermia for cardiac arrest: a practical approach
Q37310540Therapeutic hypothermia for cardiac arrest: a practical approach.
Q41129301Thrombolysis during out-of-hospital cardiac arrest: a lesson in the law of diminishing returns
Q36302404Thrombolysis with streptokinase during cardiopulmonary resuscitation: a single center experience and review of the literature
Q74166161Thrombolytic therapy during cardiopulmonary resuscitation--is the initial cardiac rhythm a critical issue?
Q74566110Thrombolytic therapy in sustained ventricular fibrillation
Q30786284Thrombolytic-Enhanced Extracorporeal Cardiopulmonary Resuscitation After Prolonged Cardiac Arrest
Q86715672[Clinical practice of systemic lysis in prehospital resuscitation. Success and complication rates]
Q81491499[Errors and risks in perioperative thrombolysis therapy]
Q87359524[Mechanical resuscitation assist devices]
Q81192910[Therapeutic hypothermia after cardiac arrest]

Search more.